Main Article Content
iron deficient chronic heart failure patients and to determine the role of brain
natreuretic peptide (BNP) in the diagnosis and monitoring of chronic heart
Methodology: The current study was a prospective analytical study. A total
of 96 patients with symptomatic chronic heart failure (CHF) were selected
through convenient sampling method. These were divided in to several
groups based upon findings of echocardiography, 06 minutes' walk test and
serum BNP. It was found that 38 patients were iron deficient. Intravenous (I/V)
iron sucrose was administered to iron deficient patients weekly for 6 weeks
followed by reassessment; the compliance rate was 87%.
Results: Patients managed with I/V therapy showed significant improvement
in all the clinical and biochemical parameters used in the study. New York
Heart Association class shift was seen in 76% of patients.
Conclusions: iron deficient induced CHF is common in our population. Parenteral
iron administration (iron sucrose) is an effective modality for managing
such patients. Serial BNP levels can be used to monitor the response to IV
Work published in JPMI is licensed under a
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.